ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
01 Dec 2023 08:51

(Mostly) Asia M&A, Nov 2023: Taisho Pharma, CIMC Vehicle, CMIC, Japan Best Rescue, Shidax

For the month of November, 16 new deals were discussed on Smartkarma with an overall deal size of ~US$13bn. The average premium for the new deals...

Logo
481 Views
Share
bearishOrigin Energy
27 Nov 2023 00:18

Merger Arb Mondays (27 Nov) - Origin, OreCorp, Healius, Taisho, JSR, Eoflow, Hollysys, Haitong Intl

This week, the highest gross spreads are Eoflow (218%), 111 (69.4%), Taisho Pharma (55.5%), Healius (48.0%), IRC (20.4%), Hollysys (12.8%), Origin...

Logo
573 Views
Share
bearishOrigin Energy
26 Nov 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Origin Energy, Healius, OreCorp, Haitong Int., Taisho Pharma

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
399 Views
Share
23 Nov 2023 17:14

KOSPI 200 and KOSDAQ 150 Rebalance Additions and Deletions Announced (December 2023)

Korea Exchange announced KOSPI 200 rebalance additions and deletions today. There were 14 new additions and deletions (7 each). There were a lot...

Logo
772 Views
Share
22 Nov 2023 12:20

KRX Short Interest Weekly (Nov 17th): Short Covers for Celltrion, Celltrion Health, Amorepacific

We analyzed KRX short interest report for the past week and highlight short interest changes in Celltrion, Celltrion Health, Amorepacific.

Logo
331 Views
Share
x